Drug Shortage Report for OMNIPAQUE 240

Last updated on 2020-09-26 History
Report ID 122250
Drug Identification Number 02172739
Brand name OMNIPAQUE 240
Common or Proper name IOHEXOL INJECTION USP
Company Name GE HEALTHCARE CANADA INC
Market Status MARKETED
Active Ingredient(s) IOHEXOL
Strength(s) 518MG
Dosage form(s) SOLUTION
Route of administration SUBARACHNOIDAL INTRAVASCULAR SUBARACHNOIDAL INTRAVASCULAR
Packaging size 20 mL
ATC code V08AB
ATC description X-RAY CONTRAST MEDIA, IODINATED
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2020-09-15
Actual start date 2020-09-16
Estimated end date 2020-09-25
Actual end date 2020-09-25
Shortage status Resolved
Updated date 2020-09-26
Company comments
Health Canada comments
Contact Address 1919 MINNESOTA COURT
MISSISSAUGA, ONTARIO
CANADA L5N 0C9
Company contact information 800-387-7146 canadainfo@ge.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-08-14 English Compare
v2 2020-08-14 French Compare
v3 2020-08-14 English Compare
v4 2020-08-14 French Compare
v5 2020-08-14 English Compare
v6 2020-08-14 French Compare
v7 2020-08-31 English Compare
v8 2020-08-31 French Compare
v9 2020-09-08 English Compare
v10 2020-09-08 French Compare
v11 2020-09-16 English Compare
v12 2020-09-16 English Compare
v13 2020-09-16 French Compare
v14 2020-09-17 English Compare
v15 2020-09-21 English Compare
v16 2020-09-21 French Compare
v17 2020-09-25 English Compare
v18 2020-09-25 French Compare
v19 2020-09-26 English Compare